ATE468864T1 - Arzneimittel gegen hörfunktionsstörungen - Google Patents
Arzneimittel gegen hörfunktionsstörungenInfo
- Publication number
- ATE468864T1 ATE468864T1 AT03748683T AT03748683T ATE468864T1 AT E468864 T1 ATE468864 T1 AT E468864T1 AT 03748683 T AT03748683 T AT 03748683T AT 03748683 T AT03748683 T AT 03748683T AT E468864 T1 ATE468864 T1 AT E468864T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical preparation
- medicinal products
- hearing impairment
- hearing disorders
- gene therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002289639 | 2002-10-02 | ||
PCT/JP2003/012674 WO2004030702A1 (ja) | 2002-10-02 | 2003-10-02 | 聴覚機能障害用医薬 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE468864T1 true ATE468864T1 (de) | 2010-06-15 |
Family
ID=32063748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03748683T ATE468864T1 (de) | 2002-10-02 | 2003-10-02 | Arzneimittel gegen hörfunktionsstörungen |
Country Status (9)
Country | Link |
---|---|
US (1) | US7390482B2 (de) |
EP (1) | EP1547618B1 (de) |
JP (1) | JP4533144B2 (de) |
CN (1) | CN1703248A (de) |
AT (1) | ATE468864T1 (de) |
AU (1) | AU2003268741B2 (de) |
CA (1) | CA2500278A1 (de) |
DE (1) | DE60332748D1 (de) |
WO (1) | WO2004030702A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2211182A1 (de) | 2009-01-16 | 2010-07-28 | Roche Diagnostics GmbH | Verfahren zur Bewertung des Schweregrades einer Leberzirrhose |
CN116440274A (zh) * | 2023-03-17 | 2023-07-18 | 烟台毓璜顶医院(青岛大学附属烟台毓璜顶医院) | c-MET及其激活剂的应用 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6136785A (en) * | 1995-08-08 | 2000-10-24 | University Of Virginia Patent Foundation | Protection from loss of sensory hair cells in the inner ear by administration of insulin-like growth factor and platelet derived growth factor |
JP3431633B2 (ja) * | 1995-08-29 | 2003-07-28 | アンジェスエムジー株式会社 | Hgf遺伝子からなる医薬 |
US5929041A (en) | 1996-02-23 | 1999-07-27 | Amgen Inc. | Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor(GDNF) protein product |
WO1998000014A1 (en) | 1996-06-28 | 1998-01-08 | The Regents Of The University Of California | Transformation and genetherapy of cells of the inner ear |
US6593290B1 (en) * | 1996-11-01 | 2003-07-15 | Genentech, Inc. | Treatment of inner ear hair cells |
US6043221A (en) | 1997-07-30 | 2000-03-28 | Amgen Inc. | Method for preventing and treating hearing loss using a neuturin protein product |
DE19807426A1 (de) | 1998-02-23 | 1999-10-14 | Otogene Biotechnologische Fors | Verfahren zur Behandlung von Erkrankungen oder Störungen des Innenohrs |
US6017886A (en) * | 1998-08-05 | 2000-01-25 | Amgen Inc. | Use of NDF peptide as growth factor for sensory epithelium |
WO2000055195A1 (en) * | 1999-03-18 | 2000-09-21 | The Regents Of The University Of California | Compositions for promoting nerve regeneration |
ATE395087T1 (de) | 1999-10-08 | 2008-05-15 | Anges Mg Inc | Hgf zur gentherapie der karidomyopathie |
CA2356701C (en) | 1999-10-29 | 2011-02-15 | Ryuichi Morishita | Gene therapy for diabetic ischemic disease |
CN1142272C (zh) * | 2000-02-02 | 2004-03-17 | 中国人民解放军军事医学科学院百环生物医学研究中心 | 携带人肝细胞生长因子基因的重组腺病毒的用途 |
JP5442173B2 (ja) * | 2000-09-14 | 2014-03-12 | 敏一 中村 | 筋萎縮性側索硬化症治療剤 |
US20030176347A1 (en) * | 2003-05-14 | 2003-09-18 | Toshikazu Nakamura | Remedies for amyotrophic lateral sclerosis |
CN1150035C (zh) * | 2000-12-21 | 2004-05-19 | 中国人民解放军军事医学科学院放射医学研究所 | 一种重组质粒及其在疾病防治中的应用 |
-
2003
- 2003-10-02 WO PCT/JP2003/012674 patent/WO2004030702A1/ja active Application Filing
- 2003-10-02 US US10/527,195 patent/US7390482B2/en active Active
- 2003-10-02 JP JP2004541278A patent/JP4533144B2/ja not_active Expired - Lifetime
- 2003-10-02 CA CA002500278A patent/CA2500278A1/en not_active Abandoned
- 2003-10-02 AT AT03748683T patent/ATE468864T1/de not_active IP Right Cessation
- 2003-10-02 AU AU2003268741A patent/AU2003268741B2/en not_active Expired - Fee Related
- 2003-10-02 DE DE60332748T patent/DE60332748D1/de not_active Expired - Lifetime
- 2003-10-02 EP EP03748683A patent/EP1547618B1/de not_active Expired - Lifetime
- 2003-10-02 CN CNA2003801008513A patent/CN1703248A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
US20060233755A1 (en) | 2006-10-19 |
AU2003268741A1 (en) | 2004-04-23 |
EP1547618A1 (de) | 2005-06-29 |
DE60332748D1 (de) | 2010-07-08 |
EP1547618B1 (de) | 2010-05-26 |
CA2500278A1 (en) | 2004-04-15 |
AU2003268741B2 (en) | 2009-06-11 |
CN1703248A (zh) | 2005-11-30 |
EP1547618A4 (de) | 2007-10-10 |
WO2004030702A1 (ja) | 2004-04-15 |
JPWO2004030702A1 (ja) | 2006-01-26 |
JP4533144B2 (ja) | 2010-09-01 |
US7390482B2 (en) | 2008-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN08079A1 (en) | Pharmaceutical compositions for the treatment of inner ear disorders | |
FR13C0012I1 (de) | ||
ECSP083351A (es) | Composiciones farmacéuticas | |
DK1256339T3 (da) | Transdermalt terapeutisk system for opnåelse af høje plasmaniveauer af rotigotin i behandlingen af Parkinsons sygdom | |
NO20040268L (no) | Nye 2H-pyridazin-3-derivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen | |
WO2004016248A8 (fr) | Forme galenique pour la delivrance colique de principes actifs | |
NO20060991L (no) | Feksofenadinsammensetning og fremgangsmate til fremstilling | |
PL398576A1 (pl) | Preparaty szczepionek, preparaty farmaceutyczne, atenuowany wirus grypy, sposoby szczepienia, sposoby zapobiegania chorobie zakaznej, sposoby leczenia lub profilaktyki nowotworów, kompozycje szczepionek i kompozycje farmaceutyczne | |
NO20043101L (no) | Farmasoytiske blandinger av oralt aktive taxanderivater som har forsterket biotilgjenglighet | |
EP1820503A3 (de) | Als Kinaseinhibitoren aktive Aminoindazol-Derivate, Herstellungsverfahren dafür und pharmazeutische Zusammensetzungen damit | |
ATE450252T1 (de) | Arzneimittel-mikroteilchen | |
BRPI0311701B8 (pt) | formulação farmacêutica de dosagem multiparticulada revestida com liberação controlada de lamotrigina | |
NO20081844L (no) | Terapeutiske forbindelser | |
HUP0203590A2 (hu) | Gyógyszerkészítmény a csonttömeg csökkenésével járó betegségek kezelésére | |
CY1105408T1 (el) | Χρησιμοποιηση στελεχων του ιου parapox ovis για την παρασκευη αντιικων φαρμακων και φαρμακων κατα του καρκινου | |
ZA200303037B (en) | Herbal pharmaceutical composition for treatment of HIV/Aids patients. | |
AU2003293593A1 (en) | Pharmaceutical preparations, use of said preparations and method for increasing the bioavailability of medicaments for peroral administration | |
EA200600603A1 (ru) | Оральная система доставки лекарственного препарата | |
WO2005055955A3 (en) | DOSING METHODS FOR ß-D-2’,3’-DIDEOXY-2’,3’-DIDEHYDRO-5-FLUOROCYTIDINE ANTIVIRAL THERAPY | |
DE60102590T2 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
HUP0500842A2 (hu) | Dronedaront tartalmazó gyógyászati készítmény parenterális adagolásra | |
EA200501697A1 (ru) | Дозируемая форма, содержащая пантопразол в качестве активного ингредиента | |
WO2005044186A3 (en) | Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same | |
PL370412A1 (en) | Pseudopolymorphic forms of carvedilol | |
ATE468864T1 (de) | Arzneimittel gegen hörfunktionsstörungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |